Heart Failure

References

Citations

1. Levy D, et al. (2002). Long-term trends in the incidence of and survival with heart failure. New England Journal of Medicine, 347(18): 1397–1443.

2. American College of Cardiology and American Heart Association (2005). ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult. Summary article. Available online: http://content.onlinejacc.org/cgi/content/full/46/6/1116.

3. Nicola PJ, et al. (2005). The risk of congestive heart failure in rheumatoid arthritis: A population-based study over 46 years. Arthritis and Rheumatism, 52(2): 412–420.

4. McKelvie R (2005). Heart failure. Clinical Evidence (13): 115–138.

5. Pitt B, et al. (1999). The effect of spironolactone on morbidity and mortality in patients with severe heart failure. New England Journal of Medicine, 341(10): 709–717.

6. Cleland JGF, et al. (2005). The effect of cardiac resynchronization on morbidity and mortality in heart failure. New England Journal of Medicine, 352(15): 1539–1549.

7. Abraham WT, et al. (2002). Cardiac resynchronization in chronic heart failure. New England Journal of Medicine, 346(24): 1845–1858.

8. Kadish A, et al. (2004). Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. New England Journal of Medicine, 350(21): 2151–2158.

9. Bristow MR, et al. (2004). Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. New England Journal of Medicine, 350(21): 2140–2150.

10. Yusef S, et al. (2002). A lifetime of prevention: The case of heart failure. Circulation, 106(24): 2997–2998.

11. Abramson JL, et al. (2001). Moderate alcohol consumption and risk of heart failure among older persons. JAMA, 285(15): 1971–1977.

12. Arnold JM, et al. (2006). Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: Diagnosis and management. Canadian Journal of Cardiology, 22(1): 23–45.

13. U.S. Food and Drug Administration (2002). FDA approves new type of defibrillator. FDA Talk Paper T02-22. Available online: http://www.fda.gov/bbs/topics/ANSWERS/2002/ANS01149.html.

14. Watson PS, et al. (1999). Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure. Journal of the American College of Cardiology, 33(6): 1549–1552.

15. Morelli V, Zoorob RJ (2000). Alternative therapies: Part II. Congestive heart failure and hypercholesterolemia. American Family Physician, 62(6): 1325–1330.

Other Works Consulted

• American Heart Association and American College of Cardiology (2006). AHA/ACC Guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update. Circulation, 113(19): 2363–2372. [Erratum in Circulation, 113(22): 847.]

• Drugs for treatment of heart failure (2006). Treatment Guidelines from the Medical Letter, 4(41): 1–4.

Go to previous section	Go to top of page	Go to next section
Author:	Douglas Dana Robin Parks, MS	Last Updated: October 23, 2006
Medical Review:	Adam Husney, MD - Family Medicine Caroline S. Rhoads, MD - Internal Medicine Stephen Fort, MD, MRCP, FRCPC - Interventional Cardiology
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.